We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-18.37%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$117M
AUM Growth
-$32.1M
Cap. Flow
-$3.56M
Cap. Flow %
-3.04%
Top 10 Hldgs %
26.79%
Holding
177
New
26
Increased
45
Reduced
40
Closed
44

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$1.3M
2
GILD icon
Gilead Sciences
GILD
+$1.2M
3
ATVI
Activision Blizzard
ATVI
+$1.18M
4
PB icon
Prosperity Bancshares
PB
+$1.08M
5
RTX icon
RTX Corp
RTX
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Technology 17.65%
3 Consumer Staples 17.28%
4 Industrials 13.42%
5 Financials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
101
Emerson Electric
EMR
$82B
$324K 0.28%
6,808
-1,100
-14% -$72.4K
WM icon
102
Waste Management
WM
$86.8B
$319K 0.27%
3,450
-1,050
-23% -$120K
GE icon
103
GE Aerospace
GE
$319B
$313K 0.27%
7,903
+1,906
+32% +$102K
CFG icon
104
Citizens Financial Group
CFG
$29.6B
$306K 0.26%
16,270
+25
+0.2% +$816
AMGN icon
105
Amgen
AMGN
$203B
$300K 0.26%
1,479
+525
+55% +$115K
SCHW
106
Charles Schwab
SCHW
$186B
$298K 0.25%
+8,850
New +$371K
WMT icon
107
Walmart Inc
WMT
$858B
$289K 0.25%
7,641
-645
-8% -$24.8K
AKAM icon
108
Akamai
AKAM
$15.1B
$288K 0.25%
+3,150
New +$292K
ALLY icon
109
Ally Financial
ALLY
$12.6B
$285K 0.24%
19,750
-1,600
-7% -$42K
AVGO icon
110
Broadcom
AVGO
$1.62T
$285K 0.24%
+12,000
New +$338K
COST icon
111
Costco
COST
$400B
$278K 0.24%
+975
New +$296K
TER icon
112
Teradyne
TER
$52B
$265K 0.23%
+4,900
New +$311K
AZN icon
113
AstraZeneca
AZN
$251B
$264K 0.23%
2,954
FCX icon
114
Freeport-McMoran
FCX
$99.6B
$261K 0.22%
38,665
+21,165
+121% +$221K
WY icon
115
Weyerhaeuser
WY
$16.1B
$259K 0.22%
15,275
-675
-4% -$17.8K
IDXX icon
116
Idexx Laboratories
IDXX
$40.2B
$254K 0.22%
+1,050
New +$274K
TEX icon
117
Terex
TEX
$6.67B
$250K 0.21%
17,400
EW icon
118
Edwards Lifesciences
EW
$49.4B
$238K 0.2%
+3,780
New +$273K
KWR icon
119
Quaker Houghton
KWR
$2.66B
$237K 0.2%
1,875
-50
-3% -$8.11K
GILD icon
120
Gilead Sciences
GILD
$181B
$236K 0.2%
3,160
-17,370
-85% -$1.2M
CMCSA icon
121
Comcast
CMCSA
$86.7B
$228K 0.19%
6,646
CP icon
122
Canadian Pacific Kansas City
CP
$78.3B
$226K 0.19%
5,150
+875
+20% +$43.1K
NFLX icon
123
Netflix
NFLX
$324B
$222K 0.19%
+5,900
New +$209K
MU icon
124
Micron Technology
MU
$1.05T
$221K 0.19%
+5,250
New +$273K
LNG icon
125
Cheniere Energy
LNG
$56B
$212K 0.18%
6,325
-300
-5% -$15.4K

Similar funds

New England Research & Management's Q1 2020 Portfolio in Review

As of Q1 2020, New England Research & Management held 177 positions worth $117M, down 22% from $149M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

New England Research & Management withdrew a net $3.56M in Q1 2020, closing 44 positions and reducing 40 holdings. Its most notable exit was Clorox, an estimated $1.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, New England Research & Management opened a new position in Intercontinental Exchange worth $981K.

  • New England Research & Management's largest Q1 2020 buy was Intercontinental Exchange: 12,150 shares worth $981K.
  • New England Research & Management added most to Union Pacific in Q1 2020, an estimated $1.01M increase.
  • New England Research & Management's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $1.2M.
  • New England Research & Management fully exited Clorox in Q1 2020, selling an estimated $1.3M.
  • New England Research & Management's ten largest holdings make up 27% of its $117M portfolio in Q1 2020.
  • New England Research & Management opened 26 new positions and closed 44 in Q1 2020.
  • New England Research & Management's portfolio value fell 22% quarter-over-quarter to $117M.

Based on New England Research & Management's 13F filing for Q1 2020, filed 15 Jun 2020.